![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessLenalidomide and pomalidomide modulate hematopoietic cell expansion and differentiation in the presence of MSC
Cytopenia is a well-documented complication in the treatment of hematological malignancies with lenalidomide and pomalidomide. Although prior studies have highlighted direct effects on hematopoietic cells to e...
-
Article
An association between a positive direct antiglobulin test and HLA-DR12 in COVID-19
SARS-CoV-2 infection has been reported to be associated with a positive direct antiglobulin test (DAT). In this study, an analysis of 40 consecutive coronavirus disease 2019 (COVID-19) cases from December 2020...
-
Article
Correction to: Menatetrenone facilitates hematopoietic cell generation in a manner that is dependent on human bone marrow mesenchymal stromal/stem cells
In the original publication of the article, the Figs. 4 C, F and 5 B, C were published with unexpected appearance of dots.
-
Article
Erratum to: Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells
-
Article
Human bone marrow mesenchymal stromal/stem cells: current clinical applications and potential for hematology
Human mesenchymal stromal/stem cells (MSCs) have capabilities for multi-differentiation, immunomodulation, and hematopoietic support. Based on these unique biological characteristics, human MSCs have been exte...
-
Article
Guest editorial: Human mesenchymal stromal/stem cell (MSC)
-
Article
Methotrexate-associated lymphoplasmacytic lymphoma complicated with type 2 cryoglobulinemia